Eli Lilly Signs $2 Billion Deal With Hong Kong Biotech Firm for AI-Powered Drug Development
Eli Lilly has signed a landmark $2.75 billion licensing agreement with AI drug developer Insilico Medicine, gaining exclusive global rights to preclinical oral drug candidates discovered…